A LINKAGE BETWEEN INFLAMMATORY BOWEL DISEASES AND TYPE 2 DIABETES
DOI:
https://doi.org/10.55766/sujst-2023-06-e0736Keywords:
IBD, Diabetes, Endocrinology, Gastroenterology, EpidemiologyAbstract
Inflammatory Bowel Diseases (IBDs) are a class of gastrointestinal chronic inflammations, comprehending Ulcerative Colitis (UC) and/or Crohn Disease (CD) and affecting genetically predisposed subjects. IBDs represent a high cost for the health system, and they are characterized by a very specific co-morbidity. For such reasons, and since a positive correlation between IBDs and Diabetes Mellitus (DM) has been observed in the past, the aim of this work is to provide such result with a more solid basis through a cohort study, considering 49 consecutive patients comorbid with IBDs and Type 2 Diabetes (T2D). A high correlation between IBDs and T2D was observed. Interestingly, UC was showed the higher correlation, with a particularly high peak within the 65 to 74 years old range. Being T2D a both environmentally and genetically driven pathology (like IBDs), these diseases association could be due to environmental factors. Furthermore, 70.8% of case-control patients (48 cases versus 96 controls, consecutively selected) were suffering from UC, while CD held the remaining 25.0% (4.2% stood for undetermined colitis). This evidences that, among IBDs, the most related to DM is UC, although CD remains a related pathology. Interestingly, CD was found to be absent in the 55-64 years old range. Conversely, cohort study highlighted 73.81% of cohort was suffering from UC, while CD held the remaining 21.43% (4.76% was for non-determined colitis). This confirms that, among IBDs, the most linked to T2D is UC.
References
Ahmad, T., Satsangi, J., Mcgovern, D., Bunce, M., and Jewell, D.P. (2001). The genetics of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 15:731-748. https://doi.org/10.1046/j.1365-2036.2001.00981.x
Ananthakrishnan, A.N., Cagan, A., Cai, T., Gainer, V.S., Shaw, S.Y., Churchill, S., Karlson, E.W., Murphy, S.N., Kohane, I. and Liao, K.P. (2015). Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics, 41:1,141-1,148. https://doi.org/10.1111/apt.13195
Bluestone, J.A., Buckner, J.H., and Herold, K.C. (2021). Immunotherapy: Building a bridge to a cure for type 1 diabetes. Science, 373(6554):510-516. https://doi.org/10.1126/science.abh1654
Dubeau, M.F., Iacucci, M., Beck, P.L., Moran, G.W., Kaplan, G.G., Ghosh, S., and Panaccione, R. (2013). Drug-induced inflammatory bowel disease and IBD-like conditions. Inflammatory Bowel Diseases, 19(2):445-456. https://doi.org/10.1002/ibd.22990
Kappelman, M.D.; Galanko, J.A.; Porter, C.Q.; Sandler, R.S. (2011). Association of paediatric inflammatory bowel disease with other immune-mediated diseases. Archives of Disease in Childhood, 96(11):1,042-1,046. https://doi.org/10.1136/archdischild-2011-300633
Katsanos, K.H., Sigounas, D.E., Christodoulou, D.K., and Tsianos, E.V. (2011). Nonsteroidal anti-inflammatory drug-induced acute ulcers in the colon. Annals of Gastroenterology, 24(4):320.
Katz, J.A. (2004). Treatment of inflammatory bowel disease with corticosteroids. Gastroenterology Clinics of North America, 33(2):171-189. https://doi.org/10.1016/j.gtc.2004.02.002
Lamb, C.A.; Kennedy, N.A.; Raine, T.; Hendy, P.A.; Smith, P.J.; Limdi, J.K.; Hayee, B.; Lomer, M.; Parkes, G.C.; Selinger, C.; Barrett, K.J.; Davies, R.J.; Bennett, C.; Gittens, S.; Dunlop, M.G.; Faiz, O.; Fraser, A.; Garrick, V.; Johnston, P.D.; Parkes, M.; … Hawthorne, A.B. (2019). British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut, 68:s1-s106. https://doi.org/10.1136/gutjnl-2019-318484
Maahs, D.M., West, N.A., Lawrence, J.M., and Mayer-Davis, E.J. (2010). Epidemiology of type 1 diabetes. Endocrinology and Metabolism Clinics, 39(3):481-497. https://doi.org/10.1016/j.ecl.2010.05.011
Manilich, E., Remzi, F.H., Fazio, V.W., Church, J.M., and Kiran, R.P. (2012). Prognostic modeling of preoperative risk factors of pouch failure. Diseases of the Colon & Rectum, 55(4):393-399. https://doi.org/10.1097/DCR.0b013e3182452594
Manos, J. (2022). The human microbiome in disease and pathology. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 130:690-705. https://doi.org/10.1111/apm.13225
Matricon, J., Barnich, N., and Ardid, D. (2010). Immunopathogenesis of inflammatory bowel disease. Self/Nonself, 1(4):299-309. https://doi.org/10.4161/self.1.4.13560
Noh, J.W., Jung, J.H., Park, J.E., Lee, J.H., Sim, K.H., Park, J., Kim, M.H., and Yoo, K.B. (2018). The relationship between age of onset and risk factors including family history and life style in Korean population with type 2 diabetes mellitus. Journal of Physical Therapy Science, 30(2):201-206. https://doi.org/10.1589/jpts.30.201
Ruel, J., Ruane, D., Mehandru, S., Gower-Rousseau, C., and Colombel, J.F. (2014). IBD across the age spectrum: is it the same disease. Nature Reviews Gastroenterology & Hepatology, 11:88-98. https://doi.org/10.1038/nrgastro.2013.240
Satsangi, J., Jewell; D.P., and Bell, J.I. (1997). The genetics of inflammatory bowel disease. Gut, 40(5):572-574. https://doi.org/10.1136/gut.40.5.572
Selinger C.P. and Leong, R.W. (2012). Mortality from Inflammatory bowel diseases. Inflammatory Bowel Diseases, 18(8):1,566-1,572. https://doi.org/10.1002/ibd.22871
Stojanović, I., Saksida, T., Miljković, Đ., and Pejnović, N. (2021). Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes. Frontiers in Immunology, 3:653560. https://doi.org/10.3389/fimmu.2021.653560
Ventham, N.T., Kennedy, N.A., Nimmo, E.R., and Satsangi, J. (2013). Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology, 145(2):293-308. https://doi.org/10.1053/j.gastro.2013.05.050
Weng, X., Liu, L., Barcellos, L.F., Allison, J.E., and Herrinton, L.J. (2007). Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. American Journal of Gastroenterology, 102(7):1,429-1,435. https://doi.org/10.1111/j.1572-0241.2007.01215.x
